Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs

Contact Dermatitis

Volumn 40, Issue 2, 1999, Pages 63-65

  Gniazdowska, Beata ^a   Ruëff, Franziska ^a   Przybilla, Bernhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Allergic contact dermatitis; Bufexamac; Etofenamate; Flufenamic acid; Indomethacin; Medicaments; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; BUFEXAMAC; DICLOFENAC; ETOFENAMATE; FELBINAC; FLUFENAMIC ACID; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTACT ALLERGY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PATCH TEST; SCHOOL CHILD; SKIN INFLAMMATION; SOFT TISSUE INJURY; TOPICAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUFEXAMAC; CHILD; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS;

EID: 0032954590     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1999.tb05992.x     Document Type: Article

References (14)

1. Bundesverband der Pharmaceutischen Industrie. Rote Liste 1997. Editio Cantor Verlag, 1997.
2. Pigatto P D, Mozzanica N, Bigardi A S, Legori A, Valsecchi R, Cusano F, Tosti A, Guarrera M, Balato N, Sertoli A. Topical NSAID allergic contact dermatitis - Italian experience. Contact Dermatitis 1993: 29: 39-40.
3. Pigatto P D, Riboldi A, Morelli M, Altomare G F, Polenghi M M. Allergic contact dermatitis from oxyphenbutazone. Contact Dermatitis 1995: 12: 236-237.
4. Frosch P J, Raulin C. Kontaktallergie auf Bufexamac. Hautarzt 1987: 38: 331-334.
5. Valsecchi R, Cainelli T. Contact dermatitis from ibuproxam. A case with cross-reactivity with ketoprofen. Contact Dermatitis 1990: 22: 51.
6. Kränke B, Szolar-Platzer C, Komericki P, Derhaschnig J, Aberer W. Epidemiological significance of bufexamac as a frequent and relevant sensitizer. Contact Dermatitis 1997: 36: 212-215.
7. Frosch P J. Aktuelle Kontaktallergene. Z Hautkr 1987: 23: 1631-1638.
8. Koch P, Bahmer F A. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases. Contact Dermatitis 1994: 31: 97-101.
9. Tada J, Toi Y, Arata J. Atopic dermatitis with severe facial lesions exacerbated by contact dermatitis from topical medicaments. Contact Dermatitis 1994: 31: 261-263.
10. Mozzanica N, Pucci M, Pigatto P D. Contact and photoallergic dermatitis to topical nonsteroidal antiinflammatory drugs (propionic acid derivatives): a study of 8 cases. In: Frosch P, Dooms-Goossens A, Lachapelle J-M, Rycroft R J G, Scheper R J. (eds) Current topics in contact dermatitis. Berlin: Springer-Verlag, 1989: 499-506.
11. Aertgeerts P, Albring M, Klaschka F, Nasemann T, Patzelt-Wenczler R, Rauhut K, Weigl B. Vergleichende Prüfung von Kamillosan Creme gegenüber steroidalen (0.25% Hydrocortison, 0.75% Fluocortinbutylester) und nichtsteroidalen (5% Bufexamac) Externa in der Erhaltungstherapie von Ekzemerkrankungen. Z Hautkr 1985: 60: 270-277.
12. Bolten W, Salzmann G, Goldmann R, Miehlke K. Plasma- und Gewebekonzentrationen von Biphenylessigsäure nach einwochiger oraler Fenbufenmedikation bzw. topischer Anwendung von Felbinac-Gel am Kniegelenk. Z Rheumatol 1989: 48: 317-322.
13. Queille-Roussel C, Duteil L, Padilla J M, Poncet M, Czernielewski J. Objective assessment of topical anti-inflammatory drug activity on experimentally induced nickel contact dermatitis: comparison between visual scoring, colorimetry, laser Doppler velocimetry and transepidermal water loss. Skin Pharmacol 1990: 3: 248-255.
14. Walchner M, Ruëff F, Przybilla B. Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction. Contact Dermatitis 1997: 36: 54-55.